comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 10:46:17 - browse：7

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： UnitedHealth, Optum discontinue NaviHealth name

Wikipedia

WSS

Why health care costs have stayed mostly flat since 2010

How AI can help patients find reliable information about doctors

Carvykti CAR

Health tech investors get more selective as pandemic boom fades

Prime Medicine, Myeloid Therapeutics clash over genome

SNAP should offer more nutrition education

hotspot

comprehensive

hotspot

New air purifier tech could be key to improving indoor air quality

Medicare Advantage beneficiaries sue Humana over algorithm use

How to save PrEP access — and even expand it

ADCs take center stage as promising cancer treatments

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ADCs take center stage as promising cancer treatments

Hepatitis C has a cure — but many Americans still lack access to it

Christmas in the PICU brings some surprising joy

Bright Health sells Medicare Advantage business to Molina

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

hotspot

Smaller biotechs seek to piggyback on weight loss drug boom

UnitedHealth, Optum discontinue NaviHealth name

HCA sued by state AG for quality issues at Mission Health

Christmas in the PICU brings some surprising joy

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

explore

Wikipedia

hotspot

knowledge